AURA - Aura Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.00
DETAILS
HIGH:
$17.00
LOW:
$17.00
MEDIAN:
$17.00
CONSENSUS:
$17.00
UPSIDE:
123.68%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 1.3 | 0 | 0 | 0 | 0.5 |
| Gross Profit | 0 | 0 | (1.3) | 0 | 0 | 0 | (0.5) |
| Operating Expenses | |||||||
| R&D Expenses | 90.3 | 73.3 | 63.9 | 42.2 | 25.2 | 18.0 | 19.1 |
| SG&A Expenses | 22.5 | 22.8 | 19.8 | 18.1 | 10.1 | 4.2 | 4.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 112.8 | 96.1 | 83.7 | 60.3 | 35.2 | 22.2 | 23.6 |
| Operating Income | |||||||
| Operating Income | (112.8) | (96.1) | (85.0) | (60.3) | (35.2) | (22.2) | (24.1) |
| Interest Expense | 0 | 0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
| Interest Income | 6.6 | 9.4 | 8.6 | 1.9 | 0.0 | 0.0 | 0.0 |
| Profitability | |||||||
| EBITDA | (111.7) | (94.9) | (83.7) | (59.1) | (34.4) | (21.4) | (23.7) |
| EBIT | (112.8) | (96.1) | (85.0) | (60.3) | (35.2) | (22.2) | (24.2) |
| Income Before Tax | (106.1) | (86.8) | (76.3) | (58.8) | (35.3) | (22.2) | (24.2) |
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0 | 0 | 0 | 0 |
| Net Income | (106.2) | (86.9) | (76.4) | (58.8) | (35.3) | (22.2) | (24.2) |
| Per Share Data | |||||||
| EPS (Basic) | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 | -0.01 |
| EPS (Diluted) | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 | -0.01 |
| Shares Outstanding | 60.3 | 49.7 | 39.6 | 29.9 | 29.2 | 29.2 | 2,922.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 59.5 | 31.7 | 41.1 | 121.6 | 149.1 | 17.4 | 32.5 |
| Short-Term Investments | 84.7 | 119.4 | 185.1 | 67.2 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.5 | 1.8 | 3.8 | 5.7 | 0.1 | 0.0 | 0.1 |
| Total Current Assets | 149.7 | 160.6 | 231.8 | 196.7 | 153.7 | 18.5 | 33.3 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 18.5 | 20.6 | 22.0 | 26.0 | 6.2 | 3.6 | 3.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.8 | 0 | 0 | 0.1 |
| Other Non-Current Assets | 1.2 | 1.3 | 1.3 | 0.4 | 0.1 | 0.1 | 0 |
| Total Non-Current Assets | 19.7 | 21.9 | 23.3 | 27.2 | 6.3 | 3.6 | 3.7 |
| Total Assets | 169.4 | 182.5 | 255.1 | 223.9 | 160.0 | 22.1 | 37.1 |
| Current Liabilities | |||||||
| Account Payables | 1.5 | 2.3 | 1.8 | 2.9 | 2.4 | 0.6 | 2.3 |
| Short-Term Debt | 3.2 | 0 | 0 | 0 | 0 | 0.0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.6 | 0.6 | 0.9 | 3.0 | 2.7 | 1.3 | 2.5 |
| Total Current Liabilities | 18.4 | 14.9 | 12.4 | 10.5 | 7.4 | 2.7 | 6.1 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 14.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 |
| Total Non-Current Liabilities | 14.1 | 15.6 | 16.9 | 17.9 | 0.4 | 0.1 | 0.1 |
| Total Liabilities | 32.5 | 30.5 | 29.2 | 28.4 | 7.7 | 2.7 | 6.3 |
| Stockholders' Equity | |||||||
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (480.4) | (374.2) | (287.3) | (210.9) | (152.1) | (116.9) | (94.7) |
| Accumulated Other Comprehensive Income | (0.1) | 0.3 | 0.5 | (0.1) | 0 | 0 | 0 |
| Total Stockholders' Equity | 136.9 | 152.0 | 225.8 | 195.6 | 152.3 | 19.4 | 30.8 |
| Total Liabilities & Equity | 169.4 | 182.5 | 255.1 | 223.9 | 160.0 | 22.1 | 37.1 |
| Debt Metrics | |||||||
| Total Debt | 17.4 | 18.8 | 19.6 | 20.9 | 1.0 | 0.0 | 0.0 |
| Net Debt | (42.1) | (12.9) | (21.5) | (100.7) | (148.1) | (17.4) | (32.4) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (106.2) | (86.9) | (76.4) | (58.8) | (35.3) | (22.2) | (24.2) |
| Depreciation & Amortization | 1.1 | 1.2 | 1.3 | 1.2 | 0.8 | 0.8 | 0.5 |
| Stock-Based Compensation | 14.3 | 11.7 | 8.8 | 6.4 | 2.3 | 0.7 | 0.5 |
| Change in Working Capital | 6.0 | (2.6) | 4.4 | (3.1) | (0.3) | (3.7) | 2.5 |
| Other Non-Cash Items | 0.0 | (3.2) | (1.9) | (0.3) | 0.0 | (0.0) | 0.1 |
| Operating Cash Flow | (84.7) | (79.8) | (63.8) | (54.6) | (32.4) | (24.3) | (20.7) |
| Investing Activities | |||||||
| Capital Expenditure | (0.4) | (1.3) | (0.7) | (1.1) | (2.1) | (0.8) | (2.2) |
| Acquisitions | 0 | 0 | 0 | 0.1 | 0 | 0 | 0 |
| Purchases of Investments | (84.0) | (59.1) | (233.7) | (119.8) | 0 | 0 | 0 |
| Sales/Maturities of Investments | 120 | 129.2 | 120.4 | 53.0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 |
| Investing Cash Flow | 35.6 | 68.8 | (114.0) | (67.9) | (2.1) | (0.8) | (2.2) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 1.5 | 0.4 | 0.3 | 0.2 | 0.1 |
| Financing Cash Flow | 77.2 | 1.6 | 97.3 | 95.6 | 166.3 | 10.0 | 39.7 |
| Cash Position | |||||||
| Net Change in Cash | 27.8 | (9.4) | (80.5) | (26.8) | 131.7 | (15.1) | 16.8 |
| Cash at Beginning | 32.5 | 41.9 | 122.4 | 149.2 | 17.5 | 32.5 | 15.7 |
| Cash at End | 60.3 | 32.5 | 41.9 | 122.4 | 149.2 | 17.5 | 32.5 |
| Free Cash Flow | (85.2) | (81.1) | (64.6) | (55.7) | (34.5) | (25.1) | (22.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | (1.3) | 0 | 0 | 0 | (0.5) |
| Operating Income | (112.8) | (96.1) | (85.0) | (60.3) | (35.2) | (22.2) | (24.1) |
| Net Income | (106.2) | (86.9) | (76.4) | (58.8) | (35.3) | (22.2) | (24.2) |
| EPS (Diluted) | -1.76 | -1.75 | -1.93 | -1.96 | -1.58 | -1.03 | -0.01 |
| Balance Sheet | |||||||
| Cash & Equivalents | 59.5 | 31.7 | 41.1 | 121.6 | 149.1 | 17.4 | 32.5 |
| Total Assets | 169.4 | 182.5 | 255.1 | 223.9 | 160.0 | 22.1 | 37.1 |
| Total Debt | 17.4 | 18.8 | 19.6 | 20.9 | 1.0 | 0.0 | 0.0 |
| Stockholders' Equity | 136.9 | 152.0 | 225.8 | 195.6 | 152.3 | 19.4 | 30.8 |
| Cash Flow | |||||||
| Operating Cash Flow | (84.7) | (79.8) | (63.8) | (54.6) | (32.4) | (24.3) | (20.7) |
| Capital Expenditure | (0.4) | (1.3) | (0.7) | (1.1) | (2.1) | (0.8) | (2.2) |
| Free Cash Flow | (85.2) | (81.1) | (64.6) | (55.7) | (34.5) | (25.1) | (22.9) |